Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Oncomutations as biomarkers of cancer risk.

Environmental and molecular mutagenesis - 1 Jan 2000

Parsons Barbara L, Myers Meagan B, Meng Fanxue, Wang Yiying, McKinzie Page B

Abstract excerpt

Cancer risk assessment impacts a range of societal needs, from the regulation of chemicals to achieving the best possible human health outcomes. Because oncogene and tumor suppressor gene mutations are necessary for the development of cancer, such mutations are ideal biomarkers to use in cancer risk assessment. Consequently, DNA-based methods to quantify particular tumor-associated hotspot point mutations (i.e.,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Mutation
Share to Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Oncogenes

Share to Risk Factors

Source

Identifiers

PMID: 20740637
DOI: 10.1002/em.20600

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Oncomutations as biomarkers of cancer risk.PMID 20740637Read ↗

ACB-PCR Quantification of Low-Frequency Hotspot Cancer-Driver Mutations.Semantic proximity Read ↗

Quantifying levels of p53 mutation in mouse skin tumors.Semantic proximity Read ↗

A comprehensive exercise in comparative mutagenesis with exciting outcome or how good are mutation assays in predicting carcinogens?Semantic proximity Read ↗

Chemically induced mutations in a MutaMouse reporter gene inform mechanisms underlying human cancer mutational signatures.Semantic proximity Read ↗

Sequencing Chemically Induced Mutations in the Mutamouse Lacz Reporter Gene Identifies Human Cancer Mutational SignaturesSemantic proximity Read ↗

Variation in organ-specific PIK3CA and KRAS mutant levels in normal human tissues correlates with mutation prevalence in corresponding carcinomas.Semantic proximity Read ↗

Mechanistic insights from biomarker studies: somatic mutations and rodent/human comparisons following exposure to a potential carcinogen.Semantic proximity Read ↗

The pattern of p53 mutations caused by PAH o-quinones is driven by 8-oxo-dGuo formation while the spectrum of mutations is determined by biological selection for dominance.Semantic proximity Read ↗

Prospects for applying genotypic selection of somatic oncomutation to chemical risk assessment.Semantic proximity Read ↗

ACB-PCR measurement of K-ras codon 12 mutant fractions in livers of Big Blue rats treated with N-hydroxy-2-acetylaminofluorene.Semantic proximity Read ↗

Accumulation of K-Ras codon 12 mutations in the F344 rat distal colon following azoxymethane exposure.Semantic proximity Read ↗

Oncogene mutations as intermediate markers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.